FDA authorizes first rapid ‘point-of-care’ test for coronavirus that can give results in 45 minutes The test, approved by the Food and Drug Administration late Friday, will be used primarily in hospitals and emergency rooms. The firm that developed the test, California-based Cepheid, plans to begin shipping it to hospitals next week.